Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

New Clinical Studies

February 18, 2003


Swedish Medical Center HIV Research Study

Purpose: HIV therapy for people who are failing their current regimen.

Study Treatment: Fixed dose tablet of abacavir/3TC once daily or abacavir twice daily and 3TC once daily in combination with tenofovir and a new PI or NNRTI.

This study involves an investigational combination of drugs.

Advertisement
Length: 48 weeks.

Study-related lab tests, including genotyping and physical exams are free. Study medications, except the new PI or NNRTI are provided at no cost.

Reimbursement for childcare and transportation are possible. Will work around your schedule (evenings, weekends, etc.).

Please contact Heather Algren for more details at: Heather Algren RN, BSN
Swedish Medical Center
747 Broadway, Rm 832
Seattle, WA 98122
Phone: 206-386-2820
Fax: 206-386-6121
Pager: 206-405-7790
E-mail: heather.algren@swedish.org


The University of Washington Virology Research Clinic

The University of Washington Virology Research Clinic is initiating studies investigating the epidemiology of human herpesvirus 8 (HHV-8). This virus has recently been implicated as an important factor in the development of Kaposi's sarcoma (KS) as well as other malignancies. At present, the mode of transmission and risk factors for acquisition of this virus are unknown. Preliminary evidence suggests that the virus is sexually transmitted. Data shows that infections are rising and that men that have sex with men are especially at risk for HHV-8.


Study: Human Herpesvirus 8 (HHV-8)


The Epidemiology of HHV-8

Purpose: To determine if HHV-8 DNA can be detected in different sites of the body. We hope to increase understanding about where the virus resides and how it is transmitted. HHV-8, also known as Kaposi's sarcoma-associated herpesvirus, is thought to cause Kaposi's sarcoma (KS) and other tumors in patients with AIDS.

Study Visits and Procedures: Participants, who qualify for the study after a screening visit, will be asked to return to the clinic for four visits on a weekly basis to donate samples of blood, saliva, tears, urine and nasal secretions.

We need:

  • Men and women over age 18

  • HIV+ or HIV-

We provide:

  • HHV-8, HIV and HSV antibody tests

  • $60 for study completion or a prorated amount


Behavioral and Biological Risk Factors for HHV-8 Transmission and Acquisition

Purpose: To determine how HHV-8, the cause of Kaposi's sarcoma in people who have AIDS, is transmitted between men who have sex with men.

Study Visits and Procedures: Participants and their partner are screened for HHV-8 at the initial appointment. If you qualify and choose to participate, the study lasts for two years. Participants are asked to come in for regular follow-up visits, where blood will be drawn every three months, a soft swab will be used to collect samples from the mouth and rectum and questionnaires will be completed. Some participants will keep a daily symptom diary.

We need:

  • Men who have sex with men and are in a steady relationship with one partner

  • HIV+ or HIV-

  • Age 18 or older

We provide:

  • HHV-8, HIV and HSV antibody tests

  • A physical examination

  • $100/person for study completion or a prorated amount





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine.
 

Tools
 

Advertisement